Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















метастатический рак печени

The private residence costs{stands} research ICON-3 in which 2039 patients Ic-IV with stages of a cancer яичников have taken part. In control group patients received карбоплатин in doze AUC> 5 or combination САР (500/50/50 mg / m2), in compared group - a combination цисплатина and паклитаксела (75/175 mg / m2). Treatment was carried out{was spent} each 3 weeks in volume of 6 rates. The preliminary data testify that time before progressing and general life expectancy was identical irrespective of used chemotherapy. Sick (57 %) in group карбоплатина and CAP received the majority таксаны as chemotherapy of the second line that explains rather good remote results. Подробнее...

People have got used to search for external enemies. Will find scientists the reason of a cancer, we shall avoid her{it} also all will be in the order. Will fail. Desease a cancer is in direct dependence on age, is approximately doubled each five years. That is, in 60 years the risk to be ill a cancer more than in 10 times is higher, than in 40 years and more than in 50 times is higher, than in 20 years. And irrespective of external "cancerogenic" factors which though exist, but incommensurably smaller weight, than this, "spontaneous" desease connected to natural deterioration and breakages of an organism at a cellular level have it. Подробнее...